Supplier Sustainability Report (SSR)

2024

STE Pharmaceuticals

Screenshot 2025-12-10 at 12_imgupscaler.ai_Beta_2K-613b5b2a

Screenshot 2025-10-14 at 15:48:22 in large size-b128c406

Screenshot 2025-10-14 at 4:14:52 p.m. in large size-f85cfdab

Descriptive data on the organisation

VSME Ref. (CSRD-EU): A-B1.012

Corporate center.Headquarters of STE Pharmaceuticals

Main activity center.

VSME Ref. (CSRD-EU): B1.006,,, B1.007, B1.010 - GRI Standard: 2-1, 2-6, 2-7, 2-8

Organization and activities

CORPORATE CENTER: Av. Universitat Autònoma, 13 Vallès Technology Park 08290 Cerdanyola del Vallès Barcelona, Spain – Number of employees: 20

MAIN PLACE OF WORK: Ctra. De Valls TV-2034 Km 6 43886 Vilabella Tarragona, Spain – No. of workers: 65

OTHER CENTERS | No. of workers: | MAIN ACTIVITY:

Development, manufacturing, and marketing of medical devices and dietary supplements for third parties (CDMO).

ACTIVITY GROUP: Pharmaceutical products, PRODUCT, MANUFACTURED PRODUCT, Food products

CNAE: 1086

Main families of products or services

Nasal cleansers

Natural cough syrups

Packaged royal jelly

Bottles for pharmaceuticals and cosmetics

Food supplements (tablets)

Production volumes per product/service family
VSME Ref. (CSRD-EU): C1.001

Nasal cleansers: 431 tons

Natural cough syrups: 230.8 tons

Packaged royal jelly: 67.7 tons

Bottles for pharmaceuticals and cosmetics: 37.6 tons

Food supplements (tablets): 36.3 tons

MAIN WEBSITE: https://www.stepharmaceuticals.com/es/

Social information

Link here to our main social networks.

PERSONNEL STRUCTURE

AGE REPRESENTATION

VSME Ref. (CSRD-EU): B1.011

VSME Ref. (CSRD-EU): A-B1.006 - GRI Standard: 102-46 /

Scope of the Report Right Supply 26000

RS26000 REPORT COVERAGE

Headquarters in Cerdanyola and production plant in Vilabella

SCOPE:

VSME Ref. (CSRD-EU): C2.002 - GRI Standard: 2-9, 2-12, 2-14

Governance

ESTRUCTURA DE GOBERNANZA:

The organization's corporate governance structure is mainly articulated through a management committee that oversees operations and strategy. Authority over economic, social, and environmental issues currently resides with senior management, which integrates sustainability into the overall strategy, although there are specific roles for operational execution.

Ref. GRI Standard: 2-3

Contact regarding this report

CONTACT PERSON: Ramón Martí – Position: Responsable de Medio Ambiente e Ingeniería

Direct phone: +34 666 570 401 Email: info@stepharmaceuticals.com

I am pleased to present our new Progress Report / COP (Communication On Progress), which documents the firm commitment of the COMPANY NAME to sustainable development, as well as the transformation of our values into actions and results of good corporate governance.

COMPANY NAME (TRADE NAME) thus demonstrates its continued support for the ten principles of the Global Compact on Human Rights, Labor Rights, the Environment, and the fight against corruption, adopting the 2030 Agenda and the Sustainable Development Goals as the main guide for its implementation.

The COP we present to you is published 100% online through theRightSupply.netdigital platform and covers the fundamental topics established by theISO 26000standardoncorporate social responsibility. The information and data declared therein have been verified by ECOMUNDIS's auditing services, certifying the annual progress ofTRADE NAMEin the non-financial matters described.

I would like to thank the work and talent of all the staff of our organization, as well as the support of our collaborators, suppliers and stakeholders.

We hope that the information included is of interest to you, please find attached a QR-link as a link to the full report.

Compliance with legal provisions

	Ref. GRI Standard: 307
	STE Pharmaceuticals has the necessary authorizations/licenses/communications to carry out its activities.

RSs: 10

Legal Compliance Management

	Ref. GRI Standard: 205, 307, 419
	STE Pharmaceuticals offers a service to keep you up to date with applicable regulations and legal requirements.

GRI Standard Ref: 2-27

RSs: 10

	GRI Standard Ref: 414

Supplier sustainability assessment (including the core subjects of ISO 26000)
SUPPLIER EVALUATION SHOULD BE ANNUAL OR BIANNUAL AND SHOULD INCLUDE A MINIMUM OF 50% OF STRATEGIC SUPPLIERS, REPRESENTATIVE OR DIRECTLY RELATED TO THE PRODUCTION OR PROVISION OF SERVICES. THE CONTENTS OF THE EVALUATION SHOULD INCLUDE HUMAN RIGHTS, LABOR PRACTICES, ENVIRONMENT, FAIR OPERATIONS, CONSUMER/CUSTOMER ISSUES, COMMUNITY DEVELOPMENT AND CORPORATE SOCIAL RESPONSIBILITY GOVERNANCE.
	STE Pharmaceuticals does not use the Right Supply platformSupply supplier evaluation.

Evaluation of relevant or material impacts on the supply chain

	VSME Ref. (CSRD-EU): C1.003 - GRI Standard: 308
	STE Pharmaceuticals conducts regular and documented environmental assessments of its suppliers on a periodic basis.


	RSs: 25

RS26000 Certificate

If you would like to boost your assessment result, review the current SSR (Supplier Sustainability Report) and become part of the Supplier Network RightSupply, you can benefit from the following advantages.

Provide a standardised and extensible response to other clients with a referenced and verifiable rating.

Receive guided technical support for the completion of the questionnaire, including a final process of validation of content sufficiency.

To have an RS 26000 Sustainability Report in several languages, aligned with the ISO 26000 standard, Agenda 2030, GRI referenced and suitable as a Communication on Progress of the United Nations Global Compact.

To be able to privately share your RS26000 Report with as many customers as you wish (via password).

Be able to publicly share your 100% digital - web based - report with your stakeholders (Open Report Mode).

Obtain the RS 26000 distinction by being part of the Supplier Network Right Supply .

Once the contents have been verified, the organization can make public or communicate its RS26000 Index to its customers and other interested parties. The RS26000 Certificate Certificate is valid for a maximum of one year from the date of its issuance and, once it has expired, the platform will keep accessible the RS26000 Report Report for a maximum of three months.

Right Supply reserves the right to revoke the RS26000 certificate and to remove from this platform those contents declared by the organization, if it is demonstrated that the organization has incurred in the omission of relevant aspects or in the falsity of the information provided.

1	STE Pharmaceuticals supports and respects the protection of internationally recognized fundamental human rights within our sphere of influence.
2	STE Pharmaceuticals guarantees that it will not cover up or collude with other companies that violate human rights.
3	STE Pharmaceuticals is committed to freedom of association and the effective recognition of the right to collective bargaining.
4	STE Pharmaceuticals is committed to the elimination of all forms of forced or compulsory labor.
5	STE Pharmaceuticals is committed to the eradication of child labor.
6	STE Pharmaceuticalsis committed to the abolition of discriminatory practices in employment and occupation.
7	STE Pharmaceuticals maintains a preventive approach that promotes environmental protection.
8	STE Pharmaceuticals encourages initiatives that promote greater environmental responsibility.
9	STE Pharmaceuticals promotes the development and dissemination of environmentally friendly technologies.
10	STE Pharmaceuticals establishes functions and controls to ensure the absence of corruption in all its forms, including extortion and bribery.


	STE Pharmaceuticals has one or more individuals with responsibilities in the area of sustainability.
	STE Pharmaceuticals has working groups or management committees that plan sustainability actions.
	STE Pharmaceuticals does NOT have an onboarding plan that conveys its values and principles.
	STE Pharmaceuticals has an environmental management system certified under the ISO 14001 standard.
	STE Pharmaceuticals has quantified the improvement in reducing its environmental impacts.
	STE Pharmaceuticals conducts internal audits of its environmental management and undergoes external audits in this area.

	RSs: 60

	Ref. GRI Standard: 301
	RAWMATERIALS. The raw materials or auxiliary materials purchased by STE Pharmaceuticals do not come from recycling processes.
	PACKAGINGThe packaging used for STE Pharmaceuticals products does not come from recycling processes.
	PACKAGINGSome of the waste generated by STE Pharmaceuticals packaging, after use or disposal, can be recovered.
	PACKAGINGSSome of the packaging used for the logistics and distribution of STE Pharmaceuticals products comes from recycling processes.
	PACKAGINGSAll waste generated by STE Pharmaceuticals packaging, after use or disposal, can be recycled.
	WASTEAny waste generated by STE Pharmaceuticals products or services after use by the customer or consumer CANNOT be recycled (it must be treated and disposed of in a landfill).


	Carbon Footprints by Products/Services \| Type of Scope \| Unit Value \| Calculation Methodology



	Organizational Carbon Footprint \| Scope type \| Unit value \| Calculation methodology

	STE Pharmaceuticals – 3.509 (Scope 1, 2, and 3. ISO 14064-1:2018)

	RSs: 7

	Ref. GRI Standard: 303-1
	STE Pharmaceuticals does not currently calculate its water footprint for any of its products, services, or organization, nor does it plan to do so in the near future.

	Water Footprints by Products/Services \| Unit Value \| Calculation Methodology




	Water footprints of organization by Products/Services \| Unit value \| Calculation methodology



	RSs: 0

Supplier Sustainability Report (SSR)

2024

STE Pharmaceuticals

Descriptive data on the organisation

Certificationsaccredited by STE Pharmaceuticals

RS26000-2024-STE-PHARMA.pdf

Environmental sustainability in the value chain

EXTRACTION AND TRANSPORT OF RAW MATERIALS

INTERMEDIATE MANUFACTURE OF COMPOUNDS/COMPONENTS

IN-HOUSE MANUFACTURE AND SERVICE

LOGISTICS, TRANSPORT AND DISTRIBUTION

CUSTOMER AND CONSUMER USE

DISPOSAL, RECYCLING AND REUSE

Agenda 2030 and Sustainable Development Goals (SDG) in Action

STE Pharmaceuticals Sustainability Index Assessment

Improve your evaluation

◉ Verification record

You can activate the platform

Information about STE Pharmaceuticals' certification and authenticity

Responsible declaration

ISO 26000 Scheme

Management approach

Human Rights

Labor Practices

Environment

Fair Operations

Consumer affairs

Community and Development

AGENDA 2030 AND LIFE CYCLE PERSPECTIVE
Location of SDG in the different phases of the product or service life cycle.


	STE Pharmaceuticals plans to implement an Energy Management System on .

	RSs: 3



	Our fleet of vehicles does NOT have electric vehicles.
	RSs: 0


	STE Pharmaceuticals Buildings designed according to sustainable architecture criteria are available.

	RSs: 10

2024

STE Pharmaceuticals

Descriptive data on the organisation

Our commitment and values

Certificationsaccredited by STE Pharmaceuticals

RS26000-2024-STE-PHARMA.pdf

Environmental sustainability in the value chain

Agenda 2030: Sustainable Development Goals Mapping

EXTRACTION AND TRANSPORT OF RAW MATERIALS

INTERMEDIATE MANUFACTURE OF COMPOUNDS/COMPONENTS

IN-HOUSE MANUFACTURE AND SERVICE

LOGISTICS, TRANSPORT AND DISTRIBUTION

CUSTOMER AND CONSUMER USE

DISPOSAL, RECYCLING AND REUSE

Environmental indicators

Waste generation VSME Ref. (CSRD-EU): B7.002 to B7.005

Energy consumption VSME (CSRD-EU) Ref.: B3.001, B3.002

CO2emissions VSME Ref. (CSRD-EU): B3.003, B3.004, C3.015, C3.016, C3.017

Water consumption and discharge VSME Ref. (CSRD-EU): B6.001

Circular economy data. Source materials UPstream

Circular economy data. Finished product DOWNstream

Green taxonomy. Eligibility and alignment.

ISO 26000. Corporate Social Responsibility

Management approach or level of integration in the organisation

List of fundamental matters in which the organization works

Agenda 2030 and Sustainable Development Goals (SDG) in Action

Objectives on which we are actively working

STE Pharmaceuticals Sustainability Index Assessment

Improve your evaluation

Improve your evaluation

RS26000 Certificate

RS26000 Index verified

◉ Verification record

You can activate the platform

Information about STE Pharmaceuticals' certification and authenticity

Responsible declaration

ISO 26000 Scheme

Management approach

Human Rights

Labor Practices

Environment

Fair Operations

Consumer affairs

Community and Development

_CO2emissions VSME Ref. (CSRD-EU): B3.003, B3.004, C3.015, C3.016, C3.017